Stock VYNE VYNE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-15 pm EST 		5-day change 1st Jan Change
2.760 USD +0.36% Intraday chart for VYNE Therapeutics Inc. -29.59% -17.61%
Jan. 06 VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo CI
Dec. 23 VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor MT

MarketScreener Editorial Features

Search
See the results
Become a member to access more news.
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. News VYNE Therapeutics Inc.
  5. MarketScreener Editorial Features